UniSuper Management Pty Ltd lifted its holdings in Albemarle Corporation (NYSE:ALB - Free Report) by 23.0% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 24,450 shares of the specialty chemicals company's stock after purchasing an additional 4,570 shares during the quarter. UniSuper Management Pty Ltd's holdings in Albemarle were worth $1,761,000 as of its most recent filing with the SEC.
Several other large investors have also bought and sold shares of the company. Toronto Dominion Bank boosted its stake in Albemarle by 0.4% during the fourth quarter. Toronto Dominion Bank now owns 39,657 shares of the specialty chemicals company's stock valued at $3,414,000 after buying an additional 158 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in Albemarle by 1.7% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 11,355 shares of the specialty chemicals company's stock valued at $977,000 after buying an additional 188 shares in the last quarter. National Pension Service boosted its stake in Albemarle by 74.5% during the first quarter. National Pension Service now owns 452 shares of the specialty chemicals company's stock valued at $33,000 after buying an additional 193 shares in the last quarter. Teachers Retirement System of The State of Kentucky boosted its stake in Albemarle by 2.6% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 9,028 shares of the specialty chemicals company's stock valued at $650,000 after buying an additional 228 shares in the last quarter. Finally, OneDigital Investment Advisors LLC boosted its stake in Albemarle by 6.7% during the first quarter. OneDigital Investment Advisors LLC now owns 3,782 shares of the specialty chemicals company's stock valued at $272,000 after buying an additional 239 shares in the last quarter. Institutional investors own 92.87% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on ALB shares. Scotiabank raised their target price on Albemarle from $65.00 to $70.00 and gave the company a "sector perform" rating in a research note on Friday, August 1st. Robert W. Baird raised their target price on Albemarle from $58.00 to $68.00 and gave the company an "underperform" rating in a research note on Friday, August 29th. JPMorgan Chase & Co. raised their target price on Albemarle from $60.00 to $80.00 and gave the company a "neutral" rating in a research note on Monday, August 18th. Piper Sandler set a $68.00 target price on Albemarle and gave the company an "underweight" rating in a report on Wednesday, May 14th. Finally, UBS Group raised Albemarle from a "sell" rating to a "neutral" rating and upped their target price for the company from $62.00 to $89.00 in a report on Tuesday, August 26th. Three equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of "Reduce" and a consensus target price of $86.47.
View Our Latest Stock Analysis on ALB
Albemarle Stock Up 1.1%
NYSE ALB opened at $73.40 on Thursday. The stock has a market cap of $8.64 billion, a PE ratio of -7.88 and a beta of 1.65. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.47 and a current ratio of 2.31. Albemarle Corporation has a twelve month low of $49.43 and a twelve month high of $113.91. The firm has a 50-day simple moving average of $76.40 and a 200 day simple moving average of $68.08.
Albemarle (NYSE:ALB - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.83) by $0.94. The business had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.23 billion. Albemarle had a negative return on equity of 1.87% and a negative net margin of 18.61%.Albemarle's quarterly revenue was down 7.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.04 earnings per share. Albemarle has set its FY 2025 guidance at EPS. On average, research analysts forecast that Albemarle Corporation will post -0.04 EPS for the current year.
Albemarle Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, September 12th will be given a dividend of $0.405 per share. The ex-dividend date is Friday, September 12th. This represents a $1.62 dividend on an annualized basis and a dividend yield of 2.2%. Albemarle's payout ratio is currently -17.38%.
Albemarle Profile
(
Free Report)
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.